Skip to content

MAKING BEST PRACTICE, EVERYDAY PRACTICE

FREE accredited digital CPD for health care professionals in South Africa

Accredited by the University of Pretoria

MAKING BEST PRACTICE, EVERYDAY PRACTICE

FREE accredited digital CPD for health care professionals in South Africa

Accredited by the University of Pretoria

Menu

Home
ABOUT
All clinical topics
SPECIAL INTEREST GROUPS
- Medical interns and registrars
Contact
Access your profile
Login

Menu

Home
ABOUT
All clinical topics
SPECIAL INTEREST GROUPS
- Medical interns and registrars
Contact
Access your profile
Login

[denovo_breadcrumbs]

Breaking through convention to simplicity in type 2 diabetes care

Questionnaire

To access this module, please register or login:

Login or Register

Breaking through convention to simplicity in type 2 diabetes care Breaking through convention to simplicity in type 2 diabetes care

Time limit: 0

Questionnaire Summary

0 of 5 Questions completed

Questions:

Information

You have already completed the questionnaire before. Hence you can not start it again.

Questionnaire is loading…

You must sign in or sign up to start the questionnaire.

You must first complete the following:

Results

Questionnaire complete. Results are being recorded.

Results

0 of 5 Questions answered correctly

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

Not categorized 0%

Regrettably, you failed to achieve the 70% pass mark required by the accrediting HPCSA.
Please try again!
For queries, please contact cpd@denovomedica.com
Congratulations on successfully completing our FREE CPD module!
Please click on button just above to download and print your CPD certificate. Alternatively, an email will be sent to you with the link to your profile, there you will find all your CPD certificates to download.
For HPCSA members, please allow 5-10 days for the CPD activity to reflect on your HPCSA profile.

1
2
3
4
5

Current
Review
Answered
Correct
Incorrect

Question 1 of 5
1. Question
1. In the first case study of a 54 male, T2DM of 5 years duration, on orals with HbA1_cof 8.1%, What would your target be for an intensified regimen?
A. 7,5%
B. 7,00%
C. <7,00%
Question 2 of 5
2. Question
2. DPP4-inhibitor therapy can be continued when GLP-1RA is introduced as they have complementary action.
A. True
B. False
Question 3 of 5
3. Question
3. What dose of iGlarLixi do you initiate and why?
A. Initiate all patients at 10 units daily; this follows the same protocol as for basal insulin, given that iGlarLixi contains basal insulin
B. Dosage should be based on the patient’s body weight; this is because it is common practice to initiate insulin at around 0.15-0.2mg/kg body weight
C. For patients uncontrolled on oral agents, a GLP-1 RA or basal insulin at <30 units – initiate at 15 units; for the patients uncontrolled on basal insulin ≥30 units – initiate at 30 units. These were the starting guidelines developed from clinical trial experience
D. Patients on oral agents or a GLP-1 RA should be initiated at 10 units daily, or at half the dose of basal insulin currently used; this is to prevent hypoglycaemia
Question 4 of 5
4. Question
4. On introduction of iGlarLixi your patient complains of nausea. What do you suggest?
A. Try to inject after a meal, rather than prior to a meal
B. Take an anti-nauseant medication
C. Counsel the patient that the nausea should be transient and will settle with time. If the nausea is severe, reduce the dose temporarily until the nausea settles and then resume up-titration
D. Stop the FRC completely and consider another form of therapy
Question 5 of 5
5. Question
5. The magic formula for getting a patient to start on an injectable is based on:
A. Clear communication on insulin not being a punishment
B. Setting of HbA1c targets which the patient understands that if not achieved will require injectables
C. Choosing agents that will minimize a patient’s prime concerns of weight gain, hypoglycaemia
D. All of the above

All Rights Reserved 2025 © deNovo Medica (Pty) Ltd in South Africa. The content on this website is intended for healthcare related professionals unless stated otherwise.

Get involved

Become a sponsor Become a medical partner author/reviewer/society

Get involved

Become a sponsor Become a medical partner author/reviewer/society

Login

Accessing this module requires a login. Please enter your credentials below!

Username or Email Address

Password

Remember Me

Lost Your Password?